BackOrphazyme A/S Overview

Orphazyme A/S Total Liabilities

Latest total liabilities for ORPH: $700K.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$702000.00
↓ 11.03% YoYΔ $-87000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Orphazyme A/S Total Liabilities History

Loading

Orphazyme A/S vs. peers: Total Liabilities Comparison

Loading

Orphazyme A/S Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orphazyme A/S (ORPH) FAQ

As of the most recent data (June 2026), ORPH shows a total liabilities of $700K. That compares with $790K in the prior-year period — down 11.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPH's total liabilities is now $700K (was $790K) — a 11.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.

Tracking ORPH's total liabilities over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $700K That compares with $790K in the prior-year period — down 11.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $700K) with ownership activity and broader fundamentals.

Orphazyme A/S's total liabilities is $700K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.